163 related articles for article (PubMed ID: 25622187)
1. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.
Sundar R; Gudey SK; Heldin CH; Landström M
Cell Cycle; 2015; 14(4):554-65. PubMed ID: 25622187
[TBL] [Abstract][Full Text] [Related]
2. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1.
Gudey SK; Sundar R; Mu Y; Wallenius A; Zang G; Bergh A; Heldin CH; Landström M
Sci Signal; 2014 Jan; 7(307):ra2. PubMed ID: 24399296
[TBL] [Abstract][Full Text] [Related]
3. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
[TBL] [Abstract][Full Text] [Related]
4. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.
Mu Y; Sundar R; Thakur N; Ekman M; Gudey SK; Yakymovych M; Hermansson A; Dimitriou H; Bengoechea-Alonso MT; Ericsson J; Heldin CH; Landström M
Nat Commun; 2011; 2():330. PubMed ID: 21629263
[TBL] [Abstract][Full Text] [Related]
5. TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.
Thakur N; Gudey SK; Marcusson A; Fu JY; Bergh A; Heldin CH; Landström M
Cell Cycle; 2014; 13(15):2400-14. PubMed ID: 25483191
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-ligase TRAF6 and TGFβ type I receptor form a complex with Aurora kinase B contributing to mitotic progression and cytokinesis in cancer cells.
Song J; Zhou Y; Yakymovych I; Schmidt A; Li C; Heldin CH; Landström M
EBioMedicine; 2022 Aug; 82():104155. PubMed ID: 35853811
[TBL] [Abstract][Full Text] [Related]
7. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
8. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
9. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI.
Zhang J; Ma W; Tian S; Fan Z; Ma X; Yang X; Zhao Q; Tan K; Chen H; Chen D; Huang BR
Cell Signal; 2014 Jan; 26(1):162-72. PubMed ID: 24103590
[TBL] [Abstract][Full Text] [Related]
10. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface.
Yakymovych I; Yakymovych M; Zang G; Mu Y; Bergh A; Landström M; Heldin CH
J Cell Biol; 2015 Jul; 210(2):319-32. PubMed ID: 26169354
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
12. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling.
Karlsson T; Sundar R; Widmark A; Landström M; Persson E
Prostate; 2018 May; 78(6):446-456. PubMed ID: 29383751
[TBL] [Abstract][Full Text] [Related]
14. Functional Characterization of a WWP1/Tiul1 Tumor-derived Mutant Reveals a Paradigm of Its Constitutive Activation in Human Cancer.
Courivaud T; Ferrand N; Elkhattouti A; Kumar S; Levy L; Ferrigno O; Atfi A; Prunier C
J Biol Chem; 2015 Aug; 290(34):21007-21018. PubMed ID: 26152726
[TBL] [Abstract][Full Text] [Related]
15. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
16. The Role of Ubiquitination to Determine Non-Smad Signaling Responses.
Gudey SK; Landström M
Methods Mol Biol; 2016; 1344():355-63. PubMed ID: 26520137
[TBL] [Abstract][Full Text] [Related]
17. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y
Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171
[TBL] [Abstract][Full Text] [Related]
18. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor.
Shi W; Sun C; He B; Xiong W; Shi X; Yao D; Cao X
J Cell Biol; 2004 Jan; 164(2):291-300. PubMed ID: 14718519
[TBL] [Abstract][Full Text] [Related]
19. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]